Ulcerative Colitis Differential Diagnoses
- Author: Marc D Basson, MD, PhD, MBA, FACS; Chief Editor: Julian Katz, MD more...
Diagnostic Considerations
Differentiation between ulcerative colitis and Crohn disease is critical to developing a treatment plan. In addition, prolonged use of cathartics, especially cascara, over many years may lead to a condition known as cathartic colon. Other problems to be considered include collagenous colitis and lymphocytic colitis (rarely requires surgery, low risk for malignancy), infectious colitis, ischemic colitis in elderly patients, and radiation colitis.
Radiologic findings in cases of acute infective enterocolitis from infection caused by Entamoeba histolytica (amebiasis), cytomegaloviral colitis, and Isospora, Salmonella, Shigella, or Yersinia may be similar to the findings seen in cases of ulcerative colitis; this is especially true with CT scans.
Ulcerative colitis versus Crohn disease
Grossly, Crohn disease is characteristically noncontiguous, with intervening, or skipped, areas of normal mucosa. The ulcerations in Crohn disease tend to be linear and often lead to the classic cobblestone appearance of the mucosa. Crohn disease may involve the entire GI tract, whereas ulcerative colitis involves only the large bowel.
Microscopically, the inflammation in ulcerative colitis and Crohn disease can appear the same, but noncaseating granulomas are present only in Crohn disease. Granulomas are present in 60% of Crohn disease specimens but are never present in ulcerative colitis specimens; therefore, their presence is specific for Crohn disease. The inflammation of Crohn disease may be transmural, whereas it is confined to the mucosa and submucosa in ulcerative colitis. Unfortunately, the differentiation is not always possible preoperatively. All large series of proctocolectomies include a subset of patients (approximately 10%) who were preoperatively thought to have ulcerative colitis but were subsequently diagnosed with Crohn disease.
The traditional idea that ulcerative colitis involves only the large bowel has been challenged. Significant gastroduodenal inflammation in children with ulcerative colitis has been reported. However, aphthous ulceration is considered unique to Crohn disease.[2] In addition, patchiness of the colonic mucosa suggestive of skip lesions may occur during the treatment phase of ulcerative colitis, leading one to question the diagnosis. These patchy areas may be seen endoscopically in as many as 38% of patients with ulcerative colitis who undergo medical therapy. Rectal sparing may also occur at some point during medical treatment of ulcerative colitis in as many as 44% of cases.[33] Proximal disease may be seen even after proctocolectomy. Capsule endoscopy has demonstrated patchy inflammation in the proximal bowel in patients with chronic pouchitis following proctocolectomy with ileal pouch reconstruction.[34]
Distinguishing ulcerative colitis from Crohn disease is important. See the table below.
Table 1. Distinguishing Ulcerative Colitis from Crohn Disease (Open Table in a new window)
| Ulcerative Colitis | Crohn Disease |
| Only colon involved | Panintestinal |
| Continuous inflammation extending proximally from rectum | Skip-lesions with intervening normal mucosa |
| Inflammation in mucosa and submucosa only | Transmural inflammation |
| No granulomas | Noncaseating granulomas |
| Perinuclear ANCA (pANCA) positive | ASCA positive |
| Bleeding (common) | Bleeding (uncommon) |
| Fistulae (rare) | Fistulae (common) |
Cathartic colon
The radiologic appearance of cathartic colon is similar to that of ulcerative colitis. In cathartic colon, the changes are more marked in the right hemicolon than in the left. The bowel is distensible, and there are inconstant areas of bowel narrowing and loss of haustra.
Other diagnostic considerations
In addition to excluding Crohn disease, guidelines from the World Gastroenterology Organization recommend ruling out the following in the differential diagnosis of ulcerative colitis[21] :
- Chronic schistosomiasis
- Amebiasis
- Intestinal tuberculosis
- Ischemic colitis
- Radiation colitis
Differential Diagnoses
- Bowel, Trauma
- Colon, Adenocarcinoma
- Colon, Diverticulitis
- Colon, Polyposis Syndromes
- Colon, Polyps
- Crohn Disease
- Gastroenteritis, Bacterial
- Gastroenteritis, Viral
- Gastrointestinal Bleeding, Lower
- Imaging in Crohn Disease
- Infectious Colitis
- Irritable Bowel Syndrome
- Megacolon, Toxic
- Mesenteric Ischemia
- Pseudomembranous Colitis Imaging
- Rectal Cancer
- Rectal Carcinoma
- Toxic Megacolon Imaging
- Tuberculosis, Gastrointestinal
Heuschen UA, Hinz U, Allemeyer EH, Stern J, Lucas M, Autschbach F. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology. Mar 2001;120(4):841-7. [Medline].
Kaufman SS, Vanderhoof JA, Young R, Perry D, Raynor SC, Mack DR. Gastroenteric inflammation in children with ulcerative colitis. Am J Gastroenterol. Jul 1997;92(7):1209-12. [Medline].
Himmel ME, Hardenberg G, Piccirillo CA, Steiner TS, Levings MK. The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease. Immunology. Oct 2008;125(2):145-53. [Medline].
Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. Jul 26 2007;448(7152):427-34. [Medline].
Lindberg E, Magnusson KE, Tysk C, Jarnerot G. Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease. Gut. Jul 1992;33(7):909-13. [Medline]. [Full Text].
Barrett JC, Lee JC, Lees CW, Prescott NJ, Anderson CA, Phillips A, et al. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet. Dec 2009;41(12):1330-4. [Medline]. [Full Text].
Vasiliauskas E. Serum immune markers in inflammatory bowel disease. Gastroenterology and Endoscopy News. Available at http://www.gastroendonews.com.
Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol. Mar 2001;96(3):730-4. [Medline].
Dubinsky MC, Ofman JJ, Urman M, Targan SR, Seidman EG. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol. Mar 2001;96(3):758-65. [Medline].
Hoffenberg EJ, Fidanza S, Sauaia A. Serologic testing for inflammatory bowel disease. J Pediatr. Apr 1999;134(4):447-52. [Medline].
Kaditis AG, Perrault J, Sandborn WJ, Landers CJ, Zinsmeister AR, Targan SR. Antineutrophil cytoplasmic antibody subtypes in children and adolescents after ileal pouch-anal anastomosis for ulcerative colitis. J Pediatr Gastroenterol Nutr. Apr 1998;26(4):386-92. [Medline].
Duggan AE, Usmani I, Neal KR, Logan RF. Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study. Gut. Oct 1998;43(4):494-8. [Medline]. [Full Text].
Andersson RE, Olaison G, Tysk C, Ekbom A. Appendectomy and protection against ulcerative colitis. N Engl J Med. Mar 15 2001;344(11):808-14. [Medline].
Levenstein S, Prantera C, Varvo V, Scribano ML, Andreoli A, Luzi C, et al. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol. May 2000;95(5):1213-20. [Medline].
Almeida MG, Kiss DR, Zilberstein B, Quintanilha AG, Teixeira MG, Habr-Gama A. Intestinal mucosa-associated microflora in ulcerative colitis patients before and after restorative proctocolectomy with an ileoanal pouch. Dis Colon Rectum. Jul 2008;51(7):1113-9. [Medline].
Felder JB, Korelitz BI, Rajapakse R, Schwarz S, Horatagis AP, Gleim G. Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study. Am J Gastroenterol. Aug 2000;95(8):1949-54. [Medline].
Bousvaros A, Zurakowski D, Duggan C, Law T, Rifai N, Goldberg NE, et al. Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J Pediatr Gastroenterol Nutr. Feb 1998;26(2):129-35. [Medline].
Garland CF, Lilienfeld AM, Mendeloff AI, Markowitz JA, Terrell KB, Garland FC. Incidence rates of ulcerative colitis and Crohn's disease in fifteen areas of the United States. Gastroenterology. Dec 1981;81(6):1115-24. [Medline].
Cotran RS, Collins T, Robbins SL, Kumar V. Pathologic Basis of Disease. Philadelphia, Pa: WB Saunders; 1998.
Jang ES, Lee DH, Kim J, Yang HJ, Lee SH, Park YS. Age as a clinical predictor of relapse after induction therapy in ulcerative colitis. Hepatogastroenterology. Sep-Oct 2009;56(94-95):1304-9. [Medline].
Gooding IR, Springall R, Talbot IC, Silk DB. Idiopathic small-intestinal inflammation after colectomy for ulcerative colitis. Clin Gastroenterol Hepatol. Jun 2008;6(6):707-9. [Medline].
Slatter C, Girgis S, Huynh H, El-Matary W. Pre-pouch ileitis after colectomy in paediatric ulcerative colitis. Acta Paediatr. Mar 2008;97(3):381-3. [Medline].
Falcone RA Jr, Lewis LG, Warner BW. Predicting the need for colectomy in pediatric patients with ulcerative colitis. J Gastrointest Surg. Mar-Apr 2000;4(2):201-6. [Medline].
Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med. Jun 30 1994;330(26):1841-5. [Medline].
Rowe FA, Walker JH, Karp LC, Vasiliauskas EA, Plevy SE, Targan SR. Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis. Am J Gastroenterol. Aug 2000;95(8):2000-8. [Medline].
Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. Apr 2001;96(4):1116-22. [Medline].
de Vlam K, Mielants H, Cuvelier C, De Keyser F, Veys EM, De Vos M. Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol. Dec 2000;27(12):2860-5. [Medline].
Cox KL, Cox KM. Oral vancomycin: treatment of primary sclerosing cholangitis in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. Nov 1998;27(5):580-3. [Medline].
Marchesa P, Lashner BA, Lavery IC, Milsom J, Hull TL, Strong SA. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol. Aug 1997;92(8):1285-8. [Medline].
Murata I, Satoh K, Yoshikawa I, Masumoto A, Sasaki E, Otsuki M. Recurrent subcutaneous abscess of the sternal region in ulcerative colitis. Am J Gastroenterol. Mar 1999;94(3):844-5. [Medline].
Kimura K, Hunter SF, Thollander MS, Loftus EV Jr, Melton LJ 3rd, O'Brien PC, et al. Concurrence of inflammatory bowel disease and multiple sclerosis. Mayo Clin Proc. Aug 2000;75(8):802-6. [Medline].
Egan CA, Meadows KP, Zone JJ. Ulcerative colitis and immunobullous disease cured by colectomy. Arch Dermatol. Feb 1999;135(2):214-5. [Medline].
Kim B, Barnett JL, Kleer CG, Appelman HD. Endoscopic and histological patchiness in treated ulcerative colitis. Am J Gastroenterol. Nov 1999;94(11):3258-62. [Medline].
Calabrese C, Fabbri A, Gionchetti P, Rizzello F, Morselli C, Liguori G, et al. Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis. Aliment Pharmacol Ther. Jun 1 2007;25(11):1311-6. [Medline].
Carucci LR, Levine MS. Radiographic imaging of inflammatory bowel disease. Gastroenterol Clin North Am. Mar 2002;31(1):93-117, ix. [Medline].
Eisenberg RL. Gastrointestinal Radiology: A Pattern Approach. Philadelphia, Pa: Lippincott-Raven; 1998:602-8.
Wiesner W, Steinbrich W. [Imaging diagnosis of inflammatory bowel disease]. Ther Umsch. Mar 2003;60(3):137-44. [Medline].
van den Broek FJ, Fockens P, Dekker E. Review article: New developments in colonic imaging. Aliment Pharmacol Ther. Dec 2007;26 Suppl 2:91-9. [Medline].
Deutsch DE, Olson AD. Colonoscopy or sigmoidoscopy as the initial evaluation of pediatric patients with colitis: a survey of physician behavior and a cost analysis. J Pediatr Gastroenterol Nutr. Jul 1997;25(1):26-31. [Medline].
Matsumoto T, Nakamura S, Jin-No Y, Sawa Y, Hara J, Oshitani N, et al. Role of granuloma in the immunopathogenesis of Crohn's disease. Digestion. 2001;63 Suppl 1:43-7. [Medline].
[Guideline] Leighton JA, Shen B, Baron TH, Adler DG, Davila R, Egan JV, et al. ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc. Apr 2006;63(4):558-65. [Medline].
Esteve M, Gisbert JP. Severe ulcerative colitis: at what point should we define resistance to steroids?. World J Gastroenterol. Sep 28 2008;14(36):5504-7. [Medline]. [Full Text].
Shen B. Crohn's disease of the ileal pouch: reality, diagnosis, and management. Inflamm Bowel Dis. Feb 2009;15(2):284-94. [Medline].
Van Assche G, Vermeire S, Rutgeerts P. Treatment of severe steroid refractory ulcerative colitis. World J Gastroenterol. Sep 28 2008;14(36):5508-11. [Medline]. [Full Text].
Ford AC, Achkar JP, Khan KJ, Kane SV, Talley NJ, Marshall JK, et al. Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis. Am J Gastroenterol. Apr 2011;106(4):601-16. [Medline].
Ford AC, Khan KJ, Sandborn WJ, Kane SV, Moayyedi P. Once-Daily Dosing vs. Conventional Dosing Schedule of Mesalamine and Relapse of Quiescent Ulcerative Colitis: Systematic Review and Meta-Analysis. Am J Gastroenterol. Dec 2011;106(12):2070-7. [Medline].
D'Haens G, Sandborn WJ, Barrett K, Hodgson I, Streck P. Once-Daily MMX® Mesalamine for Endoscopic Maintenance of Remission of Ulcerative Colitis. Am J Gastroenterol. May 8 2012;[Medline].
Ford AC, Bernstein CN, Khan KJ, Abreu MT, Marshall JK, Talley NJ, et al. Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. Apr 2011;106(4):590-9. [Medline].
Ford AC, Sandborn WJ, Khan KJ, et al. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. Apr 2011;106(4):644-59, quiz 660. [Medline].
[Best Evidence] Sandborn WJ, Rutgeerts P, Feagan BG, Reinisch W, Olson A, Johanns J, et al. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab. Gastroenterology. Oct 2009;137(4):1250-60; quiz 1520. [Medline].
Leblanc S, Allez M, Seksik P, Flourié B, Peeters H, Dupas JL, et al. Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis. Am J Gastroenterol. Apr 2011;106(4):771-7. [Medline].
Khan KJ, Ullman TA, Ford AC, et al. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol. Apr 2011;106(4):661-73. [Medline].
Sakuraba A, Sato T, Naganuma M, Morohoshi Y, Matsuoka K, Inoue N, et al. A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative colitis. J Gastroenterol. 2008;43(1):51-6. [Medline].
Miki C, Okita Y, Yoshiyama S, Araki T, Uchida K, Kusunoki M. Early postoperative application of extracorporeal leukocyte apheresis in ulcerative colitis patients: results of a pilot trial to prevent postoperative septic complications. J Gastroenterol. Jun 2007;42(6):508-9. [Medline].
Emmrich J, Petermann S, Nowak D, Beutner I, Brock P, Klingel R, et al. Leukocytapheresis (LCAP) in the management of chronic active ulcerative colitis--results of a randomized pilot trial. Dig Dis Sci. Sep 2007;52(9):2044-53. [Medline].
Ruuska T, Lahdeaho ML, Sutas Y, Ashorn M, Grönlund J. Leucocyte apheresis in the treatment of paediatric ulcerative colitis. Scand J Gastroenterol. Nov 2007;42(11):1390-1. [Medline].
Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet. Aug 21 1999;354(9179):635-9. [Medline].
Tsuda Y, Yoshimatsu Y, Aoki H, Nakamura K, Irie M, Fukuda K. Clinical effectiveness of probiotics therapy (BIO-THREE) in patients with ulcerative colitis refractory to conventional therapy. Scand J Gastroenterol. Nov 2007;42(11):1306-11. [Medline].
Simchuk EJ, Thirlby RC. Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses. World J Surg. Jul 2000;24(7):851-6. [Medline].
Farouk R, Dozois RR, Pemberton JH, Larson D. Incidence and subsequent impact of pelvic abscess after ileal pouch-anal anastomosis for chronic ulcerative colitis. Dis Colon Rectum. Oct 1998;41(10):1239-43. [Medline].
Shamberger RC, Hergrueter CA, Lillehei CW. Use of a gracilis muscle flap to facilitate delayed ileal pouch-anal anastomosis. Dis Colon Rectum. Nov 2000;43(11):1628-31. [Medline].
Karlbom U, Raab Y, Ejerblad S, Graf W, Thörn M, Pâhlman L. Factors influencing the functional outcome of restorative proctocolectomy in ulcerative colitis. Br J Surg. Oct 2000;87(10):1401-8. [Medline].
Meagher AP, Farouk R, Dozois RR, Kelly KA, Pemberton JH. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg. Jun 1998;85(6):800-3. [Medline].
Ogilvie JW Jr, Goetz L, Baxter NN, Park J, Minami S, Madoff RD. Female sexual dysfunction after ileal pouch-anal anastomosis. Br J Surg. Jul 2008;95(7):887-92. [Medline].
Cornish JA, Tan E, Teare J, Teoh TG, Rai R, Darzi AW. The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review. Dis Colon Rectum. Aug 2007;50(8):1128-38. [Medline].
Shen BO, Jiang ZD, Fazio VW, Remzi FH, Rodriguez L, Bennett AE. Clostridium difficile infection in patients with ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol. Jul 2008;6(7):782-8. [Medline].
Falk A, Olsson C, Ahrné S, Molin G, Adawi D, Jeppsson B. Ileal pelvic pouch microbiota from two former ulcerative colitis patients, analysed by DNA-based methods, were unstable over time and showed the presence of Clostridium perfringens. Scand J Gastroenterol. Aug 2007;42(8):973-85. [Medline].
Chia CS, Chew MH, Chau YP, Eu KW, Ho KS. Adenocarcinoma of the anal transitional zone after double stapled ileal pouch-anal anastomosis for ulcerative colitis. Colorectal Dis. Jul 2008;10(6):621-3. [Medline].
Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. Mar 2010;105(3):501-23; quiz 524. [Medline].
Sarigol S, Wyllie R, Gramlich T, Alexander F, Fazio V, Kay M, et al. Incidence of dysplasia in pelvic pouches in pediatric patients after ileal pouch-anal anastomosis for ulcerative colitis. J Pediatr Gastroenterol Nutr. Apr 1999;28(4):429-34. [Medline].
Pekow JR, Hetzel JT, Rothe JA, Hanauer SB, Turner JR, Hart J. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis. Inflamm Bowel Dis. Aug 2010;16(8):1352-6. [Medline].
Parente F, Molteni M, Marino B, Colli A, Ardizzone S, Greco S, et al. Are colonoscopy and bowel ultrasound useful for assessing response to short-term therapy and predicting disease outcome of moderate-to-severe forms of ulcerative colitis?: a prospective study. Am J Gastroenterol. May 2010;105(5):1150-7. [Medline].
Andersson T, Lunde OC, Johnson E, Moum T, Nesbakken A. Long-term functional outcome and quality of life after restorative proctocolectomy with ileo-anal anastomosis for colitis. Colorectal Dis. Dec 14 2009;[Medline].
Bernstein CN, Fried M, Krabshuis JH, et al. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis. Jan 2010;16(1):112-24. [Medline].
Charron M, del Rosario JF, Kocoshis S. Use of technetium-tagged white blood cells in patients with Crohn's disease and ulcerative colitis: is differential diagnosis possible?. Pediatr Radiol. Nov 1998;28(11):871-7. [Medline].
Choi JS, Potenti F, Wexner SD, Nam YS, Hwang YH, Nogueras JJ, et al. Functional outcomes in patients with mucosal ulcerative colitis after ileal pouch-anal anastomosis by the double stapling technique: is there a relation to tissue type?. Dis Colon Rectum. Oct 2000;43(10):1398-404. [Medline].
Cottliar A, Fundia A, Boerr L, Sambuelli A, Negreira S, Gil A, et al. High frequencies of telomeric associations, chromosome aberrations, and sister chromatid exchanges in ulcerative colitis. Am J Gastroenterol. Sep 2000;95(9):2301-7. [Medline].
Cucchiara S, Celentano L, de Magistris TM, Montisci A, Iula VD, Fecarotta S. Colonoscopy and technetium-99m white cell scan in children with suspected inflammatory bowel disease. J Pediatr. Dec 1999;135(6):727-32. [Medline].
da Luz Moreira A, Kiran RP, Lavery I. Clinical outcomes of ileorectal anastomosis for ulcerative colitis. Br J Surg. Jan 2010;97(1):65-9. [Medline].
Durno C, Sherman P, Harris K, Smith C, Dupuis A, Shandling B, et al. Outcome after ileoanal anastomosis in pediatric patients with ulcerative colitis. J Pediatr Gastroenterol Nutr. Nov 1998;27(5):501-7. [Medline].
Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. Nov 1 1990;323(18):1228-33. [Medline].
Fonkalsrud EW, Bustorff-Silva J. Reconstruction for chronic dysfunction of ileoanal pouches. Ann Surg. Feb 1999;229(2):197-204. [Medline]. [Full Text].
Fonkalsrud EW, Thakur A, Roof L. Comparison of loop versus end ileostomy for fecal diversion after restorative proctocolectomy for ulcerative colitis. J Am Coll Surg. Apr 2000;190(4):418-22. [Medline].
Gorfine SR, Bauer JJ, Harris MT, Kreel I. Dysplasia complicating chronic ulcerative colitis: is immediate colectomy warranted?. Dis Colon Rectum. Nov 2000;43(11):1575-81. [Medline].
Hunt LE, Eichenberger MR, Petras R, Galandiuk S. Use of a microsatellite marker in predicting dysplasia in ulcerative colitis. Arch Surg. May 2000;135(5):582-5. [Medline].
Metcalf DR, Nivatvongs S, Sullivan TM, Suwanthanma W. A technique of extending small-bowel mesentery for ileal pouch-anal anastomosis: report of a case. Dis Colon Rectum. Mar 2008;51(3):363-4. [Medline].
Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology. Apr 2006;130(4):1030-8. [Medline].
Shamberger RC, Masek BJ, Leichtner AM, Winter HS, Lillehei CW. Quality-of-life assessment after ileoanal pull-through for ulcerative colitis and familial adenomatous polyposis. J Pediatr Surg. Jan 1999;34(1):163-6. [Medline].
Treem WR, Cohen J, Davis PM, Justinich CJ, Hyams JS. Cyclosporine for the treatment of fulminant ulcerative colitis in children. Immediate response, long-term results, and impact on surgery. Dis Colon Rectum. May 1995;38(5):474-9. [Medline].
| Ulcerative Colitis | Crohn Disease |
| Only colon involved | Panintestinal |
| Continuous inflammation extending proximally from rectum | Skip-lesions with intervening normal mucosa |
| Inflammation in mucosa and submucosa only | Transmural inflammation |
| No granulomas | Noncaseating granulomas |
| Perinuclear ANCA (pANCA) positive | ASCA positive |
| Bleeding (common) | Bleeding (uncommon) |
| Fistulae (rare) | Fistulae (common) |

